T. Rowe Price Associates
CNXC icon

T. Rowe Price Associates’s Concentrix CNXC Stock Holding History

T. Rowe Price Associates’s Portfolio CNXC Stock Details CNXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Buy
39,337
+3,599
+10% +$128K ﹤0.01% 2113
2025
Q4 		$1.49M Buy
35,738
+1,543
+5% +$62.6K ﹤0.01% 1898
2025
Q3 		$1.58M Buy
34,195
+2,294
+7% +$122K ﹤0.01% 1836
2025
Q2 		$1.69M Buy
31,901
+1,075
+3% +$56.8K ﹤0.01% 1716
2025
Q1 		$1.72M Buy
30,826
+1,098
+4% +$52.6K ﹤0.01% 1677
2024
Q4 		$1.29M Sell
29,728
-3,358
-10% -$149K ﹤0.01% 1865
2024
Q3 		$1.7M Buy
33,086
+2,697
+9% +$181K ﹤0.01% 1716
2024
Q2 		$1.92M Buy
30,389
+1,593
+6% +$95.6K ﹤0.01% 1570
2024
Q1 		$1.91M Buy
28,796
+1,353
+5% +$110K ﹤0.01% 1587
2023
Q4 		$2.7M Buy
27,443
+1,064
+4% +$92.7K ﹤0.01% 1412
2023
Q3 		$2.11M Sell
26,379
-98,432
-79% -$7.72M ﹤0.01% 1439
2023
Q2 		$10.1M Sell
124,811
-102,664
-45% -$9.6M ﹤0.01% 1080
2023
Q1 		$27.7M Sell
227,475
-77,251
-25% -$10.5M ﹤0.01% 836
2022
Q4 		$40.6M Sell
304,726
-81,622
-21% -$9.92M 0.01% 722
2022
Q3 		$43.1M Buy
386,348
+9,797
+3% +$1.25M 0.01% 690
2022
Q2 		$51.1M Buy
376,551
+355,127
+1,658% +$53.4M 0.01% 865
2022
Q1 		$3.57M Buy
21,424
+2,136
+11% +$406K ﹤0.01% 1530
2021
Q4 		$3.44M Sell
19,288
-704
-4% -$126K ﹤0.01% 1556
2021
Q3 		$3.54M Sell
19,992
-990
-5% -$164K ﹤0.01% 1563
2021
Q2 		$3.37M Sell
20,982
-1,562
-7% -$240K ﹤0.01% 1589
2021
Q1 		$3.38M Buy
22,544
+2,287
+11% +$277K ﹤0.01% 1558
2020
Q4 		$2M Buy
+20,257
New +$2.02M ﹤0.01% 1636

Other funds holding CNXC

GBL
Groupe Bruxelles Lambert Brussels, Belgium $240M AUM 50.83% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates's CNXC Position: Q1 2026 in Review

T. Rowe Price Associates increased its Concentrix (CNXC) stake by 10% in Q1 2026, buying an estimated $128K and bringing the position to 39,337 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2113.

T. Rowe Price Associates first reported a position in CNXC in Q4 2020 and has held it in 22 quarters since. The position peaked at $51.1M in Q2 2022. 301 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • T. Rowe Price Associates held 39,337 shares of Concentrix worth $1.08M as of Q1 2026.
  • T. Rowe Price Associates bought 3,599 Concentrix shares in Q1 2026, an estimated $128K.
  • Concentrix made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2113 holding.
  • T. Rowe Price Associates first reported a position in Concentrix in Q4 2020 and has held it in 22 quarters since.
  • T. Rowe Price Associates's Concentrix position peaked at $51.1M in Q2 2022.
  • 301 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.